United States Sickle Cell Anemia Drug Market Report 2016

November 2016 | 99 pages | ID: U68BAD6008FEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Sickle Cell Anemia Drug

Revenue, means the sales value of Sickle Cell Anemia Drug

This report studies sales (consumption) of Sickle Cell Anemia Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GlycoMimetics
• Bluebird bio
• GlaxoSmithKline
• Mast Therapeutics
• Bayer AG
• Eli Lilly
• Regen biopharma

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Sickle Cell Anemia Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Sickle Cell Anemia Drug Market Report 2016

1 SICKLE CELL ANEMIA DRUG OVERVIEW

1.1 Product Overview and Scope of Sickle Cell Anemia Drug
1.2 Classification of Sickle Cell Anemia Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Sickle Cell Anemia Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Sickle Cell Anemia Drug (2011-2021)
  1.4.1 United States Sickle Cell Anemia Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES SICKLE CELL ANEMIA DRUG COMPETITION BY MANUFACTURERS

2.1 United States Sickle Cell Anemia Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Sickle Cell Anemia Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Sickle Cell Anemia Drug Average Price by Manufactures (2015 and 2016)
2.4 Sickle Cell Anemia Drug Market Competitive Situation and Trends
  2.4.1 Sickle Cell Anemia Drug Market Concentration Rate
  2.4.2 Sickle Cell Anemia Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES SICKLE CELL ANEMIA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Sickle Cell Anemia Drug Sales and Market Share by Type (2011-2016)
3.2 United States Sickle Cell Anemia Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Sickle Cell Anemia Drug Price by Type (2011-2016)
3.4 United States Sickle Cell Anemia Drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES SICKLE CELL ANEMIA DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Sickle Cell Anemia Drug Sales and Market Share by Application (2011-2016)
4.2 United States Sickle Cell Anemia Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES SICKLE CELL ANEMIA DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 GlycoMimetics
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GlycoMimetics Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bluebird bio
  5.2.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bluebird bio Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline
  5.3.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Mast Therapeutics
  5.4.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Mast Therapeutics Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bayer AG
  5.5.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bayer AG Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Eli Lilly
  5.6.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Eli Lilly Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Regen biopharma
  5.7.2 Sickle Cell Anemia Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Regen biopharma Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 SICKLE CELL ANEMIA DRUG MANUFACTURING COST ANALYSIS

6.1 Sickle Cell Anemia Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Sickle Cell Anemia Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Sickle Cell Anemia Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Sickle Cell Anemia Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES SICKLE CELL ANEMIA DRUG MARKET FORECAST (2016-2021)

10.1 United States Sickle Cell Anemia Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Sickle Cell Anemia Drug Sales Forecast by Type (2016-2021)
10.3 United States Sickle Cell Anemia Drug Sales Forecast by Application (2016-2021)
10.4 Sickle Cell Anemia Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sickle Cell Anemia Drug
Table Classification of Sickle Cell Anemia Drug
Figure United States Sales Market Share of Sickle Cell Anemia Drug by Type in 2015
Table Application of Sickle Cell Anemia Drug
Figure United States Sales Market Share of Sickle Cell Anemia Drug by Application in 2015
Figure United States Sickle Cell Anemia Drug Sales and Growth Rate (2011-2021)
Figure United States Sickle Cell Anemia Drug Revenue and Growth Rate (2011-2021)
Table United States Sickle Cell Anemia Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Sickle Cell Anemia Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Sickle Cell Anemia Drug Sales Share by Manufacturers
Figure 2016 Sickle Cell Anemia Drug Sales Share by Manufacturers
Table United States Sickle Cell Anemia Drug Revenue by Manufacturers (2015 and 2016)
Table United States Sickle Cell Anemia Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Sickle Cell Anemia Drug Revenue Share by Manufacturers
Table 2016 United States Sickle Cell Anemia Drug Revenue Share by Manufacturers
Table United States Market Sickle Cell Anemia Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Sickle Cell Anemia Drug Average Price of Key Manufacturers in 2015
Figure Sickle Cell Anemia Drug Market Share of Top 3 Manufacturers
Figure Sickle Cell Anemia Drug Market Share of Top 5 Manufacturers
Table United States Sickle Cell Anemia Drug Sales by Type (2011-2016)
Table United States Sickle Cell Anemia Drug Sales Share by Type (2011-2016)
Figure United States Sickle Cell Anemia Drug Sales Market Share by Type in 2015
Table United States Sickle Cell Anemia Drug Revenue and Market Share by Type (2011-2016)
Table United States Sickle Cell Anemia Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Sickle Cell Anemia Drug by Type (2011-2016)
Table United States Sickle Cell Anemia Drug Price by Type (2011-2016)
Figure United States Sickle Cell Anemia Drug Sales Growth Rate by Type (2011-2016)
Table United States Sickle Cell Anemia Drug Sales by Application (2011-2016)
Table United States Sickle Cell Anemia Drug Sales Market Share by Application (2011-2016)
Figure United States Sickle Cell Anemia Drug Sales Market Share by Application in 2015
Table United States Sickle Cell Anemia Drug Sales Growth Rate by Application (2011-2016)
Figure United States Sickle Cell Anemia Drug Sales Growth Rate by Application (2011-2016)
Table GlycoMimetics Basic Information List
Table GlycoMimetics Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlycoMimetics Sickle Cell Anemia Drug Sales Market Share (2011-2016)
Table Bluebird bio Basic Information List
Table Bluebird bio Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bluebird bio Sickle Cell Anemia Drug Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Sickle Cell Anemia Drug Sales Market Share (2011-2016)
Table Mast Therapeutics Basic Information List
Table Mast Therapeutics Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mast Therapeutics Sickle Cell Anemia Drug Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Sickle Cell Anemia Drug Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Sickle Cell Anemia Drug Sales Market Share (2011-2016)
Table Regen biopharma Basic Information List
Table Regen biopharma Sickle Cell Anemia Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regen biopharma Sickle Cell Anemia Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sickle Cell Anemia Drug
Figure Manufacturing Process Analysis of Sickle Cell Anemia Drug
Figure Sickle Cell Anemia Drug Industrial Chain Analysis
Table Raw Materials Sources of Sickle Cell Anemia Drug Major Manufacturers in 2015
Table Major Buyers of Sickle Cell Anemia Drug
Table Distributors/Traders List
Figure United States Sickle Cell Anemia Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Sickle Cell Anemia Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Sickle Cell Anemia Drug Production Forecast by Type (2016-2021)
Table United States Sickle Cell Anemia Drug Consumption Forecast by Application (2016-2021)